¿Interacciona la microbiota humana con el tratamiento inmunosupresor de las enfermedades reumatológicas autoinmunes sistémicas? Revisión sistemática Noemí Franco-Domingo; Patricia Saiz-López; Loreto Carmona-Ortells;

Survival of first line biological and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in Chile Marcos Cruces Olivar; Allan D. Burboa; Yolanda M. Gómez;

Association between hypothyroidism and elderly-onset rheumatoid arthritis: A cross-sectional study at national hospital in Peru Paul J. Tejada-Llacsa; Vidia Lumbe Diaz; Carlos Diaz-Arocutipa;